Vicarious Surgical (RBOTW) Liabilities and Shareholders Equity (2020 - 2025)
Vicarious Surgical (RBOTW) reported Liabilities and Shareholders Equity of $19.6 million for Q4 2025, down 71.08% year-over-year from $67.7 million in Q4 2024, and down 33.28% quarter-over-quarter from $29.3 million in Q3 2025.
Vicarious Surgical (RBOTW) Liabilities and Shareholders Equity (2020 - 2025) Analysis & Trends
Vicarious Surgical (RBOTW) has 6 years of Liabilities and Shareholders Equity data on file, last reported at $19.6 million in Q4 2025.
- Liabilities and Shareholders Equity for Q4 2025 came in at $19.6 million, down 71.08% year-over-year; the trailing twelve-month figure through Dec 2025 was $144.9 million (down 58.25% YoY), and the FY2025 annual result was $19.6 million, down 71.08% from the prior year.
- Liabilities and Shareholders Equity fell to $19.6 million in Q4 2025 per RBOTW's latest filing, from $29.3 million in the prior quarter.
- Over five years, Liabilities and Shareholders Equity peaked at $346.4 million in Q1 2021 and troughed at $19.6 million in Q4 2025.
- A 5-year average of $133.6 million and a median of $120.5 million in 2023 frame the typical range for Liabilities and Shareholders Equity.
- The sharpest annual moves came in 2021 and 2025: Liabilities and Shareholders Equity jumped 89224.63% in 2021, then sank 71.08% in 2025.
- A 5-year view of Liabilities and Shareholders Equity shows it stood at $181.7 million in 2021, then fell by 22.78% to $140.3 million in 2022, then dropped by 14.56% to $119.9 million in 2023, then tumbled by 43.5% to $67.7 million in 2024, then sank by 71.08% to $19.6 million in 2025.
- Business Quant data shows RBOTW's Liabilities and Shareholders Equity at $19.6 million in Q4 2025, $29.3 million in Q3 2025, and $40.9 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 91.49 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 31.92 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 6.63 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 37.13 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 10.74 Bn |
| 10 | Vicarious Surgical | - | - | - | 19.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 19.58 Mn |
| Sep 30, 2025 | 29.35 Mn |
| Jun 30, 2025 | 40.89 Mn |
| Mar 31, 2025 | 55.05 Mn |
| Dec 31, 2024 | 67.72 Mn |
| Sep 30, 2024 | 80.62 Mn |
| Jun 30, 2024 | 93.35 Mn |
| Mar 31, 2024 | 105.29 Mn |
| Dec 31, 2023 | 119.86 Mn |
| Sep 30, 2023 | 132.05 Mn |
| Jun 30, 2023 | 104.53 Mn |
| Mar 31, 2023 | 121.09 Mn |
| Dec 31, 2022 | 140.29 Mn |
| Sep 30, 2022 | 150.68 Mn |
| Jun 30, 2022 | 164.05 Mn |
| Mar 31, 2022 | 179.97 Mn |
| Dec 31, 2021 | 181.68 Mn |
| Sep 30, 2021 | 193.36 Mn |
| Jun 30, 2021 | 345.54 Mn |
| Mar 31, 2021 | 346.35 Mn |